Paper35548698
The intriguing biology and chemistry of fosfomycin: the only marketed phosphonate antibiotic.
Cao Y and 4 others. RSC Adv, 2019. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. The intriguing biology and chemistry of fosfomycin: the only marketed phosphonate antibiotic. Papers, record 35548698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35548698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The intriguing biology and chemistry of fosfomycin: the only marketed phosphonate antibiotic.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References84
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26960938 | Fosfomycin. | Clin Microbiol Rev | 2016 | https://conductscience.org/library/papers/26960938 | PubMed |
| 2 | 11171958 | Interaction of the herbicide glyphosate with its target enzyme 5-enolpyruvylshikimate 3-phosphate synthase in atomic detail. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11171958 | PubMed |
| 3 | 20034765 | Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. | Int J Antimicrob Agents | 2010 | https://conductscience.org/library/papers/20034765 | PubMed |
| 4 | 22096042 | Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. | J Antimicrob Chemother | 2012 | https://conductscience.org/library/papers/22096042 | PubMed |
| 5 | 7396959 | The herbicide glyphosate is a potent inhibitor of 5-enolpyruvyl-shikimic acid-3-phosphate synthase. | Biochem Biophys Res Commun | 1980 | https://conductscience.org/library/papers/7396959 | PubMed |
| 6 | 12668580 | Target site penetration of fosfomycin in critically ill patients. | J Antimicrob Chemother | 2003 | https://conductscience.org/library/papers/12668580 | PubMed |
| 7 | 8994972 | Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin. | Structure | 1996 | https://conductscience.org/library/papers/8994972 | PubMed |
| 8 | 22615277 | Different biosynthetic pathways to fosfomycin in Pseudomonas syringae and Streptomyces species. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22615277 | PubMed |
| 9 | 4605290 | The mechanism of action of fosfomycin (phosphonomycin). | Ann N Y Acad Sci | 1974 | https://conductscience.org/library/papers/4605290 | PubMed |
| 10 | 12678760 | Aminophosphonic acids of potential medical importance. | Curr Med Chem Anticancer Agents | 2001 | https://conductscience.org/library/papers/12678760 | PubMed |
| 11 | 1633621 | The discovery of cell wall active antibacterial antibiotics. | Crit Rev Biotechnol | 1992 | https://conductscience.org/library/papers/1633621 | PubMed |
| 12 | 8075065 | Kinetics, stoichiometry, and identification of the reactive thiolate in the inactivation of UDP-GlcNAc enolpyruvoyl transferase by the antibiotic fosfomycin. | Biochemistry | 1994 | https://conductscience.org/library/papers/8075065 | PubMed |
| 13 | 17113999 | Heterologous production of fosfomycin and identification of the minimal biosynthetic gene cluster. | Chem Biol | 2006 | https://conductscience.org/library/papers/17113999 | PubMed |
| 14 | 30988619 | Fosfomycin: the characteristics, activity, and use in critical care. | Ther Clin Risk Manag | 2019 | https://conductscience.org/library/papers/30988619 | PubMed |
| 15 | 17220970 | New insight into the mechanism of methyl transfer during the biosynthesis of fosfomycin. | Chem Commun (Camb) | 2007 | https://conductscience.org/library/papers/17220970 | PubMed |
| 16 | 14677948 | Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms. | J Am Chem Soc | 2003 | https://conductscience.org/library/papers/14677948 | PubMed |
| 17 | 11222759 | Radical SAM, a novel protein superfamily linking unresolved steps in familiar biosynthetic pathways with radical mechanisms: functional characterization using new analysis and information visualization methods. | Nucleic Acids Res | 2001 | https://conductscience.org/library/papers/11222759 | PubMed |
| 18 | 27787975 | Phosphonate Biochemistry. | Chem Rev | 2017 | https://conductscience.org/library/papers/27787975 | PubMed |
| 19 | 2182591 | Fosfadecin and fosfocytocin, new nucleotide antibiotics produced by bacteria. | J Antibiot (Tokyo) | 1990 | https://conductscience.org/library/papers/2182591 | PubMed |
| 20 | 3759643 | Production of fosfomycin (phosphonomycin) by Pseudomonas syringae. | J Antibiot (Tokyo) | 1986 | https://conductscience.org/library/papers/3759643 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42074201 | Drug Repurposing Uncovers New Chemical Scaffolds as Potent Urease Inhibitors: A Comprehensive Computational Study. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074201 | PubMed |
| 42005539 | One-year multicenter surveillance of Fosfomycin resistance Enterobacterales: the rise of FosA3-producing P. mirabilis. | Curr Res Microb Sci | 2026 | https://conductscience.org/library/papers/42005539 | PubMed |
| 41599013 | Fosfomycin Resistance: An Update on the Anthropogenic Impact Through Agriculture. | Pathogens | 2025 | https://conductscience.org/library/papers/41599013 | PubMed |
| 40433956 | Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity. | Elife | 2025 | https://conductscience.org/library/papers/40433956 | PubMed |
| 39720961 | Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis. | Drugs | 2025 | https://conductscience.org/library/papers/39720961 | PubMed |
| 39452211 | Determinants of Antibiotic Resistance and Virulence Factors in the Genome of Escherichia coli APEC 36 Strain Isolated from a Broiler Chicken with Generalized Colibacillosis. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39452211 | PubMed |
| 39203413 | Role of Carbon, Nitrogen, Phosphate and Sulfur Metabolism in Secondary Metabolism Precursor Supply in Streptomyces spp. | Microorganisms | 2024 | https://conductscience.org/library/papers/39203413 | PubMed |
| 38767810 | Effect of fosfomycin-induced hypernatremia on patients' hospital stay length and survival. | Ir J Med Sci | 2024 | https://conductscience.org/library/papers/38767810 | PubMed |
| 37765315 | Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37765315 | PubMed |
| 37242370 | Reliability of E-Tests and the Phoenix Automated Method in Assessing Susceptibility to IV Fosfomycin-Comparative Studies Relative to the Reference Method. | Pathogens | 2023 | https://conductscience.org/library/papers/37242370 | PubMed |
| 36834560 | Advances in the Synthesis and Analysis of Biologically Active Phosphometabolites. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834560 | PubMed |
| 36558775 | Assessment of the Susceptibility of Clinical Gram-Negative and Gram-Positive Bacterial Strains to Fosfomycin and Significance of This Antibiotic in Infection Treatment. | Pathogens | 2022 | https://conductscience.org/library/papers/36558775 | PubMed |
| 36297159 | Serendipitous Discovery of a Competitive Inhibitor of FraB, a Salmonella Deglycase and Drug Target. | Pathogens | 2022 | https://conductscience.org/library/papers/36297159 | PubMed |
| 35365617 | Harnessing phosphonate antibiotics argolaphos biosynthesis enables a synthetic biology-based green synthesis of glyphosate. | Nat Commun | 2022 | https://conductscience.org/library/papers/35365617 | PubMed |
| 35310391 | The Impact of the Antibiotic Fosfomycin on Wastewater Communities Measured by Flow Cytometry. | Front Microbiol | 2021 | https://conductscience.org/library/papers/35310391 | PubMed |
| 34943747 | Inhibition of MurA Enzyme from Escherichia coli and Staphylococcus aureus by Diterpenes from Lepechinia meyenii and Their Synthetic Analogs. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34943747 | PubMed |
| 34768931 | Phosphonates as Unique Components of Plant Seeds-A Promising Approach to Use Phosphorus Profiles in Plant Chemotaxonomy. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34768931 | PubMed |
| 34244614 | Fosfomycin and nitrofurantoin: classic antibiotics and perspectives. | J Antibiot (Tokyo) | 2021 | https://conductscience.org/library/papers/34244614 | PubMed |
| 34074759 | Biosynthesis of fosfomycin in pseudomonads reveals an unexpected enzymatic activity in the metallohydrolase superfamily. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34074759 | PubMed |
| 34056400 | QM/MM Study of the Fosfomycin Resistance Mechanism Involving FosB Enzyme. | ACS Omega | 2021 | https://conductscience.org/library/papers/34056400 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35548698
GET https://conductscience.org/api/papers/v1/35548698/references?page=2